Nikolay Alexandrovich Grishin
Nikolay Alexandrovich Grishin has a total of 78 co-authors. Here are the top co-authors by number of shared publications:
- Vladimir Sergeevich Trifanov
P.A. Hertsen Moscow Oncology Research Institute – branch of National Medical Radiology Research Center, Ministry of Health of Russia
13 shared publications - Ruslan Ivanovich Moshurov
National Medical Research Radiological Center
11 shared publications - Nadezhda N. Volchenko
P.A. Hertsen Moscow Oncology Research Institute — Branch of the National Medical Research Radiological Centre
7 shared publications - A. A. Troitskiy
P.A. Herzen Moscow Oncology Research Institute — Branch of the National Medical Radiology Research Center of the Ministry of Health of Russia
6 shared publications - Dmitry Vladimirovich Sidorov
National Medical Research Radiological Center, Ministry of Health of the Russian Federation, Moscow, Russia
6 shared publications - Mariya Andreevna Chernichenko
National Medical Research Radiological Center
6 shared publications
Latest Publications
- Open Access
- 12 October 2026
- Published by Association of Oncologist Real Clinical Practice OncoPractitioner in Clinical Case in Oncology
- Vol. 4 (1) , 41-49
Isolated metastatic lesion of the sacrum in rectal cancer: experience in performing simultaneous surgical treatment
Metastatic bone damage in colorectal cancer occurs in no more than 10% of patients. Even less often, the disease manifests itself by the presence of synchronous isolated secondary foci in the sacrum. Despite the atypical localization, there are pathogenetically justified prerequisites for the realization of this metastatic pattern in rectal cancer. Due
- 12 October 2026
- Published by Association of Oncologist Real Clinical Practice OncoPractitioner in Clinical Case in Oncology
- Vol. 4 (1) , 41-49
Open AccessIsolated metastatic lesion of the sacrum in rectal cancer: experience in performing simultaneous surgical treatment
Metastatic bone damage in colorectal cancer occurs in no more than 10% of patients. Even less often, the disease manifests itself by the presence of synchronous isolated secondary foci in the sacrum. Despite the atypical localization, there are pathogenetically justified prerequisites for the realization of this metastatic pattern in rectal cancer. Due
- 10 August 2026
- Published by Media Sphere Publishing Group in P.A. Herzen Journal of Oncology
- Vol. 15 (4)
Complications and adverse events of cytoreductive surgery in malignant peritoneal lesions
Cytoreductive surgery combined with intraoperative intraperitoneal chemotherapy is the treatment of choice for patients with malignant peritoneal lesions. Objective. To evaluate the validity and safety of surgical interventions in patients with primary and disseminated peritoneal lesions by analyzing the frequency and severity of intra- and postoperative complications. Material and methods. The Abdominal Department of the P.A. Hertzen Moscow Oncology Research Institute has accumulated experience in performing 168 cytoreductive surgeries with various intraoperative antitumor methods in patients with peritoneal carcinomatosis. Among them, 125 surgeries were for pseudomyxoma peritonei, 25 for mesothelioma, and in 18 cases, the indication for intervention was peritoneal metastases of colorectal cancer. Results. Complications and serious adverse events were identified in 31 (18.4%) patients. Grade III—IV complications occurred in 6.5% of patients. Postoperative mortality was 2.9%, which does not exceed the rate for major surgical interventions such as pancreaticoduodenectomy, simultaneous esophageal resection and reconstruction, and extended hemihepatectomy. Conclusion. Cytoreductive surgery for malignant peritoneal lesions is a sufficiently safe and effective treatment method for this category of patients.
- 10 August 2026
- Published by Media Sphere Publishing Group in P.A. Herzen Journal of Oncology
- Vol. 15 (4)
Complications and adverse events of cytoreductive surgery in malignant peritoneal lesions
Cytoreductive surgery combined with intraoperative intraperitoneal chemotherapy is the treatment of choice for patients with malignant peritoneal lesions. Objective. To evaluate the validity and safety of surgical interventions in patients with primary and disseminated peritoneal lesions by analyzing the frequency and severity of intra- and postoperative complications. Material and methods. The Abdominal Department of the P.A. Hertzen Moscow Oncology Research Institute has accumulated experience in performing 168 cytoreductive surgeries with various intraoperative antitumor methods in patients with peritoneal carcinomatosis. Among them, 125 surgeries were for pseudomyxoma peritonei, 25 for mesothelioma, and in 18 cases, the indication for intervention was peritoneal metastases of colorectal cancer. Results. Complications and serious adverse events were identified in 31 (18.4%) patients. Grade III—IV complications occurred in 6.5% of patients. Postoperative mortality was 2.9%, which does not exceed the rate for major surgical interventions such as pancreaticoduodenectomy, simultaneous esophageal resection and reconstruction, and extended hemihepatectomy. Conclusion. Cytoreductive surgery for malignant peritoneal lesions is a sufficiently safe and effective treatment method for this category of patients.
- 14 May 2026
- Published by Media Sphere Publishing Group in P.A. Herzen Journal of Oncology
- Vol. 15 (2)
Surgical treatment of neuroendocrine tumors of the pancreas of distal localisation
Objective. To study the immediate and long-term results of surgical treatment of patients with distal neuroendocrine neoplasms of the pancreas. Material and methods. The results of examination and treatment of 39 patients with neuroendocrine tumors of pancreas body and tail who underwent distal resections are presented. The analysis on the nature of operations, morphological structure of masses, postoperative complications is carried out. The main attention was paid to the factors of unfavourable prognosis and their influence on the survival rate. Results. Complications of III A-B degree according to Clavien– Dindo occurred in 6 (15.4%) patients, there was no postoperative lethality. The 5-year cumulative overall and recurrence-free survival rates were 78.6% and 64.3%, respectively. Conclusion. Surgical treatment of patients with neuroendocrine distal pancreatic tumors is justified by low lethality and frequency of serious complications. Long-term results confirm oncological validity of active therapeutic tactics.
- 14 May 2026
- Published by Media Sphere Publishing Group in P.A. Herzen Journal of Oncology
- Vol. 15 (2)
Surgical treatment of neuroendocrine tumors of the pancreas of distal localisation
Objective. To study the immediate and long-term results of surgical treatment of patients with distal neuroendocrine neoplasms of the pancreas. Material and methods. The results of examination and treatment of 39 patients with neuroendocrine tumors of pancreas body and tail who underwent distal resections are presented. The analysis on the nature of operations, morphological structure of masses, postoperative complications is carried out. The main attention was paid to the factors of unfavourable prognosis and their influence on the survival rate. Results. Complications of III A-B degree according to Clavien– Dindo occurred in 6 (15.4%) patients, there was no postoperative lethality. The 5-year cumulative overall and recurrence-free survival rates were 78.6% and 64.3%, respectively. Conclusion. Surgical treatment of patients with neuroendocrine distal pancreatic tumors is justified by low lethality and frequency of serious complications. Long-term results confirm oncological validity of active therapeutic tactics.
- 11 December 2025
- Published by Media Sphere Publishing Group in P.A. Herzen Journal of Oncology
- Vol. 14 (6)
Possibilities of drug treatment for pseudomyxoma peritonei of appendiceal origin
The article is devoted to a rather rare pathology — mucinous tumor of the appendix with the formation of pseudomyxoma peritonei. There are currently no generally accepted clinical recommendations based on the results of randomized clinical trials regarding the treatment of this pathology. The role of drug therapy for pseudomyxoma peritonei is an understudied topic, but current evidence suggests that there is a lack of highly effective systemic therapy regimens. This paper demonstrates a clinical observation of the successful treatment of a patient with pseudomyxoma peritonei of appendiceal origin based on a personalized approach taking into account the molecular genetic features of the tumor.
- 11 December 2025
- Published by Media Sphere Publishing Group in P.A. Herzen Journal of Oncology
- Vol. 14 (6)
Possibilities of drug treatment for pseudomyxoma peritonei of appendiceal origin
The article is devoted to a rather rare pathology — mucinous tumor of the appendix with the formation of pseudomyxoma peritonei. There are currently no generally accepted clinical recommendations based on the results of randomized clinical trials regarding the treatment of this pathology. The role of drug therapy for pseudomyxoma peritonei is an understudied topic, but current evidence suggests that there is a lack of highly effective systemic therapy regimens. This paper demonstrates a clinical observation of the successful treatment of a patient with pseudomyxoma peritonei of appendiceal origin based on a personalized approach taking into account the molecular genetic features of the tumor.
- 19 August 2025
- Published by Media Sphere Publishing Group in P.A. Herzen Journal of Oncology
- Vol. 14 (4)
Parenchyma-preserving surgical treatment option for a patient with Klatskin tumor with atypical anatomy of hilus structures
The publication presents a successful experience of treating a patient with Klatskin tumor, type IIIa according to Bismuth–Corlette, complicated by biliary cirrhosis of the liver. Low functional reserve of the remnant led to the need for parenchyma-preserving surgery, and the atypical anatomy of the liver porta structures ensured its possibility. In the discussion of the problem of treatment of cholangiocarcinoma of the extrahepatic bile ducts, data on the epidemiology of the disease, various classifications of the process and the surgical treatment methods determined by them, prognosis and survival factors are provided.
- 19 August 2025
- Published by Media Sphere Publishing Group in P.A. Herzen Journal of Oncology
- Vol. 14 (4)
Parenchyma-preserving surgical treatment option for a patient with Klatskin tumor with atypical anatomy of hilus structures
The publication presents a successful experience of treating a patient with Klatskin tumor, type IIIa according to Bismuth–Corlette, complicated by biliary cirrhosis of the liver. Low functional reserve of the remnant led to the need for parenchyma-preserving surgery, and the atypical anatomy of the liver porta structures ensured its possibility. In the discussion of the problem of treatment of cholangiocarcinoma of the extrahepatic bile ducts, data on the epidemiology of the disease, various classifications of the process and the surgical treatment methods determined by them, prognosis and survival factors are provided.
- Open Access
- 13 July 2025
- Published by ECO-Vector LLC in Russian Journal of Oncology
- Vol. 30 (2) , 144-151
Results of successful application of radiofrequency ablation in the treatment of hepatocellular carcinoma (HCC)
BACKGROUND: One of the surgical treatment methods for hepatocellular carcinoma is energy-based tumor ablation, indicated in patients with BCLC stage 0 and stage A disease when liver resection or transplantation is not feasible. CASE DESCRIPTION: A 72-year-old patient with hepatocellular carcinoma, cT1bN0M0 (stage IB), underwent percutaneous radiofrequency ablation because of severe comorbidities, including cirrhosis secondary to nonalcoholic steatohepatitis, Child-Pugh class B (7 points), portal hypertension, dilatation of the portal venous system, portosystemic shunts, grade 1 ascites, splenomegaly, and grade 2 esophageal varices (endoscopic ligation of grade 2 varices was performed in 2018), as well as type 2 diabetes mellitus. Chest and abdominal computed tomography with intravenous contrast at 3, 6, and 9 months after the procedure revealed no evidence of tumor progression. CONCLUSION: At the P. Hertsen Moscow Oncology Research Institute, the results of successful radiofrequency ablation in hepatocellular carcinoma were analyzed. The method demonstrated favorable short-term outcomes, a minimal number of complications, and favorable long-term outcomes, with overall 5-year survival reaching 94% of cases and overall 10-year survival 32.3% of cases, including patients with severe comorbidities. Over the past 10 years, at the P. Hertsen Moscow Oncology Research Institute, radiofrequency ablation has been used as an independent treatment modality in 5 patients. Overall 3-year recurrence-free survival was achieved in 80% of patients (4 patients), and overall 5-year survival in 20% of patients (1 patient).
- 13 July 2025
- Published by ECO-Vector LLC in Russian Journal of Oncology
- Vol. 30 (2) , 144-151
Open AccessResults of successful application of radiofrequency ablation in the treatment of hepatocellular carcinoma (HCC)
BACKGROUND: One of the surgical treatment methods for hepatocellular carcinoma is energy-based tumor ablation, indicated in patients with BCLC stage 0 and stage A disease when liver resection or transplantation is not feasible. CASE DESCRIPTION: A 72-year-old patient with hepatocellular carcinoma, cT1bN0M0 (stage IB), underwent percutaneous radiofrequency ablation because of severe comorbidities, including cirrhosis secondary to nonalcoholic steatohepatitis, Child-Pugh class B (7 points), portal hypertension, dilatation of the portal venous system, portosystemic shunts, grade 1 ascites, splenomegaly, and grade 2 esophageal varices (endoscopic ligation of grade 2 varices was performed in 2018), as well as type 2 diabetes mellitus. Chest and abdominal computed tomography with intravenous contrast at 3, 6, and 9 months after the procedure revealed no evidence of tumor progression. CONCLUSION: At the P. Hertsen Moscow Oncology Research Institute, the results of successful radiofrequency ablation in hepatocellular carcinoma were analyzed. The method demonstrated favorable short-term outcomes, a minimal number of complications, and favorable long-term outcomes, with overall 5-year survival reaching 94% of cases and overall 10-year survival 32.3% of cases, including patients with severe comorbidities. Over the past 10 years, at the P. Hertsen Moscow Oncology Research Institute, radiofrequency ablation has been used as an independent treatment modality in 5 patients. Overall 3-year recurrence-free survival was achieved in 80% of patients (4 patients), and overall 5-year survival in 20% of patients (1 patient).
- Open Access
- 1 January 2025
- Published by Euroasian Scientific and Industrial Chamber, Ltd. in Современные проблемы науки и образования (Modern Problems of Science and Education)
- No. №3 2025,p. 28
CLINICO-MORPHOLOGICAL PREDICTORS OF PANCREATIC FISTULA FORMATION IN PATIENTS AFTER PROXIMAL PANCREATIC RESECTIONS AND NEOADJUVANT CHEMOTHERAPY
- 1 January 2025
- Published by Euroasian Scientific and Industrial Chamber, Ltd. in Современные проблемы науки и образования (Modern Problems of Science and Education)
- No. №3 2025,p. 28
Open AccessCLINICO-MORPHOLOGICAL PREDICTORS OF PANCREATIC FISTULA FORMATION IN PATIENTS AFTER PROXIMAL PANCREATIC RESECTIONS AND NEOADJUVANT CHEMOTHERAPY
- 5 October 2024
- Published by ECO-Vector LLC in Russian Journal of Oncology
- Vol. 29 (1) , 23-32
Risk factors of pancreatic fistula after distal pancreas resections: an observational retrospective study
BACKGROUND: The main complication of surgical pancreas interventions is the pancreatic fistula (PF) — abnormal secretion of pancreatic secretions into the abdominal cavity, which can lead to more severe complications. At the same time, some predictors of PF remain poorly understood. AIM: To investigate the risk factors for the development of PF after distal pancreatic resection. MATERIALS AND METHODS: The study included 40 patients who underwent distal resection. The influence of various clinical parameters on the development of PF after surgery was evaluated. Methods of mathematical modeling and correlation analysis were used. Mathematical modeling was carried out using the Random forest machine learning algorithm, and the indicator of the relative importance of the “importance” parameters was evaluated. RESULTS: According to the Random forest model, on day 1 after surgery, the most significant predictors of the development of PF were: the volume of neoplasm, age and stage of the oncological process, for which “importance” was 53.2, 13.7 and 12.5 (AUC ROC=62%); on day 3–5, “importance” was 61.7, 11.5 and 5.2 (AUC ROC=79%). An increase in the concentration of pancreatic amylase in blood plasma for 2–3 and 3–5 days correlated with its increase in the drainage discharge for 5-7 days after the intervention (r=0.48 and 0.76; p 0.05). A correlation was found between the level of amylase in the drainage discharge on 3–5 days after the intervention and the level of leukocytes according to the general blood test (r=0.62, p 0.05). CONCLUSION: An increase in plasma amylase levels is the main risk factor for the development of PF. An increase in the concentration of amylase in the drainage discharge can be considered as a potential risk factor for the development of pancreatic fistulas with clinical manifestations in the following days. The stage of the oncological process, the size of the neoplasm and the age of the patient are also risk factors.
- 5 October 2024
- Published by ECO-Vector LLC in Russian Journal of Oncology
- Vol. 29 (1) , 23-32
Risk factors of pancreatic fistula after distal pancreas resections: an observational retrospective study
BACKGROUND: The main complication of surgical pancreas interventions is the pancreatic fistula (PF) — abnormal secretion of pancreatic secretions into the abdominal cavity, which can lead to more severe complications. At the same time, some predictors of PF remain poorly understood. AIM: To investigate the risk factors for the development of PF after distal pancreatic resection. MATERIALS AND METHODS: The study included 40 patients who underwent distal resection. The influence of various clinical parameters on the development of PF after surgery was evaluated. Methods of mathematical modeling and correlation analysis were used. Mathematical modeling was carried out using the Random forest machine learning algorithm, and the indicator of the relative importance of the “importance” parameters was evaluated. RESULTS: According to the Random forest model, on day 1 after surgery, the most significant predictors of the development of PF were: the volume of neoplasm, age and stage of the oncological process, for which “importance” was 53.2, 13.7 and 12.5 (AUC ROC=62%); on day 3–5, “importance” was 61.7, 11.5 and 5.2 (AUC ROC=79%). An increase in the concentration of pancreatic amylase in blood plasma for 2–3 and 3–5 days correlated with its increase in the drainage discharge for 5-7 days after the intervention (r=0.48 and 0.76; p 0.05). A correlation was found between the level of amylase in the drainage discharge on 3–5 days after the intervention and the level of leukocytes according to the general blood test (r=0.62, p 0.05). CONCLUSION: An increase in plasma amylase levels is the main risk factor for the development of PF. An increase in the concentration of amylase in the drainage discharge can be considered as a potential risk factor for the development of pancreatic fistulas with clinical manifestations in the following days. The stage of the oncological process, the size of the neoplasm and the age of the patient are also risk factors.
- 10 July 2024
- Published by ECO-Vector LLC in Russian Journal of Oncology
- Vol. 28 (3) , 131-144
The problem of pancreatic fistula development after pancreatic surgery in oncological patients
Pancreaticoduodenal and distal resections are crucial components of pancreatic cancer treatment. Pancreatic fistula is one of the most common complications of these surgeries. The main criterion for the diagnosis of pancreatic fistula is the increase of amylase drain level more than 3 times from the normal blood level. Pancreatic fistulas worsen the long-term results of cancer treatment and increase the risk of bleeding per an erosion of visceral vessels, pancreatitis and peritonitis, as well as increase the duration of hospital stay. Risk factors for pancreatic fistula can be split in two categories: patient-related and procedure-related. The patient-related risk factors are: male sex, age more than 70 years, small or large diameter of the pancreatic duct, epithelial type of the malignancy, comorbidities and a high volume of drainage fluid in the postoperative period. Surgical risk factors are: the severity of intraoperative blood loss, “soft” pancreas, duration of surgery and surgical techniques. The most effective method for fistula prophylaxis is intraoperative risk evaluation with initial pancreatectomy in case of high risk. At the same time, it is possible to use medical glues and pharmacological methods for prevention and treatment of postoperative pancreatic fistulas, but further investigations are required. Thus, prevention and treatment of postoperative pancreatic fistulas is a crucial component of management of patients who undergo surgery for pancreatic malignancies.
- 10 July 2024
- Published by ECO-Vector LLC in Russian Journal of Oncology
- Vol. 28 (3) , 131-144
The problem of pancreatic fistula development after pancreatic surgery in oncological patients
Pancreaticoduodenal and distal resections are crucial components of pancreatic cancer treatment. Pancreatic fistula is one of the most common complications of these surgeries. The main criterion for the diagnosis of pancreatic fistula is the increase of amylase drain level more than 3 times from the normal blood level. Pancreatic fistulas worsen the long-term results of cancer treatment and increase the risk of bleeding per an erosion of visceral vessels, pancreatitis and peritonitis, as well as increase the duration of hospital stay. Risk factors for pancreatic fistula can be split in two categories: patient-related and procedure-related. The patient-related risk factors are: male sex, age more than 70 years, small or large diameter of the pancreatic duct, epithelial type of the malignancy, comorbidities and a high volume of drainage fluid in the postoperative period. Surgical risk factors are: the severity of intraoperative blood loss, “soft” pancreas, duration of surgery and surgical techniques. The most effective method for fistula prophylaxis is intraoperative risk evaluation with initial pancreatectomy in case of high risk. At the same time, it is possible to use medical glues and pharmacological methods for prevention and treatment of postoperative pancreatic fistulas, but further investigations are required. Thus, prevention and treatment of postoperative pancreatic fistulas is a crucial component of management of patients who undergo surgery for pancreatic malignancies.
- 23 April 2024
- Published by Media Sphere Publishing Group in P.A. Herzen Journal of Oncology
- Vol. 13 (6)
Hepatocellular carcinoma associated with nonalcoholic fatty liver disease
The clinical observation is devoted to the successful surgical treatment of a patient with primary liver cancer that developed against the background of non-alcoholic fatty liver disease. This pathology as a predictor of hepatocellular carcinoma has recently come out on top in frequency, displacing hepatitis and cirrhosis of viral etiology. The literature review provides data on the incidence of steatosis and steatohepatitis in developed countries of the world, as well as mechanisms of hepatocarcinogenesis against the background of these conditions, morphological characteristics of these subtypes of liver carcinoma, and diagnostic difficulties.
- 23 April 2024
- Published by Media Sphere Publishing Group in P.A. Herzen Journal of Oncology
- Vol. 13 (6)
Hepatocellular carcinoma associated with nonalcoholic fatty liver disease
The clinical observation is devoted to the successful surgical treatment of a patient with primary liver cancer that developed against the background of non-alcoholic fatty liver disease. This pathology as a predictor of hepatocellular carcinoma has recently come out on top in frequency, displacing hepatitis and cirrhosis of viral etiology. The literature review provides data on the incidence of steatosis and steatohepatitis in developed countries of the world, as well as mechanisms of hepatocarcinogenesis against the background of these conditions, morphological characteristics of these subtypes of liver carcinoma, and diagnostic difficulties.